Reviewing Allied Healthcare Products (NASDAQ:AHPI) and Bone Biologics (OTC:BBLG)
Reviewing Allied Healthcare Products (NASDAQ:AHPI) and Bone Biologics (OTC:BBLG)
Allied Healthcare Products (NASDAQ:AHPI – Get Rating) and Bone Biologics (OTC:BBLG – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
Allied Healthcare Products（納斯達克股票代碼：AHPI — Get Ratings）和Bone Biologics（場外交易代碼：BBLG — 獲取評級）都是小型醫療公司，但哪項投資更好？我們將根據兩家公司的盈利能力、分析師建議、收益、機構所有權、股息、估值和風險對比這兩家公司。
Analyst Ratings
分析師評級
This is a summary of recent ratings and price targets for Allied Healthcare Products and Bone Biologics, as provided by MarketBeat.com.
這是Marketbeat.com提供的Allied Healthcare Products和Bone Biologics的最新評級和目標價格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Allied Healthcare Products | 0 | 0 | 0 | 0 | N/A |
| Bone Biologics | 0 | 0 | 1 | 0 | 3.00 |
| 賣出評級 | 保持收視率 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 聯合醫療保健產品 | 0 | 0 | 0 | 0 | 不適用 |
| 骨生物製劑 | 0 | 0 | 1 | 0 | 3.00 |
Bone Biologics has a consensus target price of $2.25, suggesting a potential upside of 806.16%. Given Bone Biologics' higher possible upside, analysts plainly believe Bone Biologics is more favorable than Allied Healthcare Products.
Bone Biologics的共識目標價爲2.25美元，這表明潛在的上漲空間爲806.16％。鑑於Bone Biologics可能有更高的上行空間，分析師顯然認爲Bone Biologics比Allied Healthcare Product
Volatility and Risk
波動性和風險
Institutional and Insider Ownership
機構所有權和內部所有權
4.2% of Allied Healthcare Products shares are owned by institutional investors. Comparatively, 7.6% of Bone Biologics shares are owned by institutional investors. 5.1% of Allied Healthcare Products shares are owned by insiders. Comparatively, 71.5% of Bone Biologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
聯合醫療產品4.2％的股份由機構投資者持有。相比之下，Bone Biologics的7.6％股票由機構投資者持有。5.1％的Allied Healthcare Products股份由內部人士持有。相比之下，Bone Biologics有71.5％的股份由內部人士持有。強大的機構所有權表明，捐贈基金、大型基金經理和對沖基金認爲，從長遠來看，股票的表現將超過市場。
Profitability
盈利能力
This table compares Allied Healthcare Products and Bone Biologics' net margins, return on equity and return on assets.
該表比較了Allied Healthcare Products和Bone Biologics的淨利潤率、股本回報率和資產
| Net Margins | Return on Equity | Return on Assets | |
| Allied Healthcare Products | -19.82% | -70.44% | -31.16% |
| Bone Biologics | N/A | 7,587.33% | 7,258.20% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 聯合醫療保健產品 | -19.82% | -70.44% | -31.16% |
| 骨生物製劑 | 不適用 | 7,587.33% | 7,258.20% |
Valuation and Earnings
估值和收益
This table compares Allied Healthcare Products and Bone Biologics' gross revenue, earnings per share (EPS) and valuation.
該表比較了Allied Healthcare Products和Bone Biologics的總收入、每股收益（EPS）和
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Allied Healthcare Products | $27.05 million | 0.15 | -$5.36 million | ($1.34) | -0.75 |
| Bone Biologics | N/A | N/A | -$1.61 million | N/A | N/A |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| 聯合醫療保健產品 | 2705 萬美元 | 0.15 | -536 萬美元 | (1.34 美元) | -0.75 |
| 骨生物製劑 | 不適用 | 不適用 | -161 萬美元 | 不適用 | 不適用 |
Bone Biologics has lower revenue, but higher earnings than Allied Healthcare Products.
與聯合醫療產品相比，Bone Biologics的收入較低，但收益更高。
Summary
摘要
Bone Biologics beats Allied Healthcare Products on 9 of the 10 factors compared between the two stocks.
與兩隻股票相比，Bone Biologics在10個因素中的9個因素上擊敗了Allied Healthcare
About Allied Healthcare Products
關於 Allied 醫療保健產品
(Get Rating)
（獲取評分）
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which includes construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients in hospital rooms, operating theaters, and intensive care areas; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in St. Louis, Missouri.
Allied Healthcare Products, Inc. 在世界各地的一系列醫院和其他場所生產和銷售用於醫療保健行業的呼吸產品。該公司提供呼吸護理/麻醉產品，包括空氣壓縮機、校準設備、加溼器、露營帳篷和設備烘乾機，以及呼吸道一次性產品，例如氧氣管產品、口罩、套管和呼吸機迴路；以及家庭呼吸護理產品，包括鋁氧氣瓶、氧氣調節器、氣動霧化器、便攜式抽吸設備和一系列呼吸器一次性產品。它還提供醫用氣體設備，包括由壁掛式醫療系統組件、中央站泵和壓縮機以及前壁組成的建築產品；包括流量計、真空調節器和壓力調節器的調節設備和抽吸設備，以及用於測量、調節、監控醫用氣體並將其從牆壁管道或設備輸送到病房、手術室和重症監護區的患者的相關適配器、接頭和軟管；以及用於短暫提供氧氣的一次性氧氣瓶經期。此外，該公司還提供緊急醫療產品，包括呼吸/復甦產品，例如按需復甦閥、便攜式復甦系統、袋裝口罩和相關產品、緊急運輸呼吸機、精密氧氣調節器、微型器、多路器和加溼器；以及創傷和患者處理產品，包括脊柱固定產品、氣動防休克服和創傷燒傷套件。它爲醫院、醫院設備經銷商、醫院建築承包商、家庭醫療保健經銷商、緊急醫療產品經銷商等提供服務。該公司成立於1979年，總部位於密蘇里州聖路易斯。
About Bone Biologics
關於 Bone Biologics
(Get Rating)
（獲取評分）
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Bone Biologics Corporation是一家醫療器械公司，專注於使用重組人蛋白在脊柱融合中的骨再生。該公司的NELL-1/DBX是一種組合產品，它是一種骨刺激性重組蛋白，可爲骨再生提供靶向特異性控制。它正在開發 NELL-1/DBX 融合設備，用於治療骨骼成熟的椎間盤退行性疾病患者，其水平與 L4-S1 相同。該公司的平臺技術已應用於在脊柱、骨科、普通骨科、整形重建、神經外科、介入放射學和運動醫學等外科專業領域提供增強的療效。它與加州大學洛杉磯分校技術開發小組簽訂了許可協議，用於脊柱融合應用的 NELL-1 的開發和商業化。該公司成立於 2004 年，總部位於馬薩諸塞州伯靈頓。
Receive News & Ratings for Allied Healthcare Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收Allied醫療產品的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Allied Healthcare Products及相關公司的最新新聞和分析師評級的簡明每日摘要。